{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:45:58Z","timestamp":1768970758517,"version":"3.49.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technological Innovation Project for College Students in Zhejiang Province","award":["2023R410003"],"award-info":[{"award-number":["2023R410003"]}]},{"name":"the Zhejiang Provincial Natural Science Foundation","award":["LY21H290003"],"award-info":[{"award-number":["LY21H290003"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81503296"],"award-info":[{"award-number":["81503296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Zhejiang Scientific Research Fund of Traditional Chinese Medicine","award":["2020ZB085"],"award-info":[{"award-number":["2020ZB085"]}]},{"name":"Specific Program of Scientific Research of Zhejiang Chinese Medicine University for Affiliated Hospital","award":["2023FSYYZZ04"],"award-info":[{"award-number":["2023FSYYZZ04"]}]},{"name":"Project of Academic Inheritance Studio of Famous and Aged Chinese Medicine Experts in Zhejiang Province","award":["GZS2021022"],"award-info":[{"award-number":["GZS2021022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15438-5","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T10:37:16Z","timestamp":1765363036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein"],"prefix":"10.1186","volume":"26","author":[{"given":"Yaonan","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiawan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peicheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baodong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keding","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Huei","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dijiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"1","key":"15438_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","volume":"14","author":"H Liu","year":"2021","unstructured":"Liu H. Emerging agents and regimens for AML. J Hematol Oncol. 2021;14(1):49.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"15438_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s40425-018-0432-9","volume":"6","author":"R Jitschin","year":"2018","unstructured":"Jitschin R, Saul D, Braun M, Tohumeken S, Volkl S, Kischel R, et al. CD33\/CD3-bispecific T-cell engaging (BiTE(R)) antibody construct targets monocytic AML myeloid-derived suppressor cells. J Immunother Cancer. 2018;6(1):116.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"15438_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1515\/jtim-2016-0041","volume":"5","author":"M Hong","year":"2017","unstructured":"Hong M, He G. 2016 revision to the WHO classification of acute myeloid leukemia. J Transl Int Med. 2017;5(2):69\u201371.","journal-title":"J Transl Int Med"},{"issue":"8","key":"15438_CR4","first-page":"3829","volume":"12","author":"MY Yao","year":"2022","unstructured":"Yao MY, Wang YF, Zhao Y, Ling LJ, He Y, Wen J, et al. BCL-2 inhibitor synergizes with PI3Kdelta inhibitor and overcomes FLT3 inhibitor resistance in acute myeloid leukaemia. Am J Cancer Res. 2022;12(8):3829\u201342.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"15438_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11912-024-01503-y","volume":"26","author":"M Wysota","year":"2024","unstructured":"Wysota M, Konopleva M, Mitchell S. Novel therapeutic targets in acute myeloid leukemia (AML). Curr Oncol Rep. 2024;26(4):409\u201320.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"15438_CR6","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41408-023-00911-w","volume":"13","author":"NJ Short","year":"2023","unstructured":"Short NJ, Nguyen D, Ravandi F. Treatment of older adults with FLT3-mutated AML: emerging paradigms and the role of frontline FLT3 inhibitors. Blood Cancer J. 2023;13(1):142.","journal-title":"Blood Cancer J"},{"issue":"12","key":"15438_CR7","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321.","journal-title":"Nat Genet"},{"issue":"10","key":"15438_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/s41576-021-00387-z","volume":"22","author":"WR Reay","year":"2021","unstructured":"Reay WR, Cairns MJ. Advancing the use of genome-wide association studies for drug repurposing. Nat Rev Genet. 2021;22(10):658\u201371.","journal-title":"Nat Rev Genet"},{"issue":"10","key":"15438_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/CIRCULATIONAHA.119.040180","volume":"140","author":"M Chong","year":"2019","unstructured":"Chong M, Sjaarda J, Pigeyre M, Mohammadi-Shemirani P, Lali R, Shoamanesh A, et al. Novel drug targets for ischemic stroke identified through Mendelian randomization analysis of the blood proteome. Circulation. 2019;140(10):819\u201330.","journal-title":"Circulation"},{"key":"15438_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110107","volume":"126","author":"S Sun","year":"2020","unstructured":"Sun S, Fang W. Current understandings on T-cell prolymphocytic leukemia and its association with TCL1 proto-oncogene. Biomed Pharmacother. 2020;126:110107.","journal-title":"Biomed Pharmacother"},{"issue":"22","key":"15438_CR11","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","volume":"35","author":"MA Kamat","year":"2019","unstructured":"Kamat MA, Blackshaw JA, Young R, Surendran P, Burgess S, Danesh J, et al. Phenoscanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019;35(22):4851\u20133.","journal-title":"Bioinformatics"},{"issue":"9","key":"15438_CR12","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U Vosa","year":"2021","unstructured":"Vosa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet"},{"issue":"7944","key":"15438_CR13","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"5","key":"15438_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"15438_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"15438_CR16","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"key":"15438_CR17","doi-asserted-by":"publisher","first-page":"884298","DOI":"10.3389\/fcimb.2022.884298","volume":"12","author":"JS Tan","year":"2022","unstructured":"Tan JS, Ren JM, Fan L, Wei Y, Hu S, Zhu SS, et al. Genetic predisposition of anti-cytomegalovirus immunoglobulin G levels and the risk of 9 cardiovascular diseases. Front Cell Infect Microbiol. 2022;12:884298.","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"15438_CR18","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"issue":"4","key":"15438_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006706","volume":"13","author":"L Folkersen","year":"2017","unstructured":"Folkersen L, Fauman E, Sabater-Lleal M, Strawbridge RJ, Franberg M, Sennblad B, et al. Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease. PLoS Genet. 2017;13(4):e1006706.","journal-title":"PLoS Genet"},{"issue":"6","key":"15438_CR20","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1038\/s41380-022-01507-9","volume":"27","author":"YT Deng","year":"2022","unstructured":"Deng YT, Ou YN, Wu BS, Yang YX, Jiang Y, Huang YY, et al. Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood. Mol Psychiatry. 2022;27(6):2849\u201357.","journal-title":"Mol Psychiatry"},{"key":"15438_CR21","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.15555.1","volume":"4","author":"S Burgess","year":"2019","unstructured":"Burgess S, Davey Smith G, Davies NM, Dudbridge F, Gill D, Glymour MM, et al. Guidelines for performing Mendelian randomization investigations: update for summer 2023. Wellcome Open Res. 2019;4:186.","journal-title":"Wellcome Open Res"},{"issue":"10","key":"15438_CR22","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Cancer Genome Atlas Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"3","key":"15438_CR23","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5(3):100625.","journal-title":"Innovation (Camb)"},{"issue":"269","key":"15438_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","journal-title":"Sci Signal"},{"issue":"5","key":"15438_CR25","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"6220","key":"15438_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science"},{"key":"15438_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jare.2024.10.003","volume":"74","author":"D Wu","year":"2024","unstructured":"Wu D, Li M, Hong Y, Jin L, Liu Q, Sun C, Li L, Han X, Deng S, Feng Y, et al. Integrated stress response activation induced by usnic acid alleviates BCL-2 inhibitor ABT-199 resistance in acute myeloid leukemia. J Adv Res. 2024;74:621\u201335.","journal-title":"J Adv Res"},{"issue":"4","key":"15438_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/10286020.2017.1339696","volume":"20","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Niu JJ, Cheng XC, Lu YX, Jun XF, Zhao XR, et al. Chemical constituents from Bletilla striata and their NO production suppression in RAW 264.7 macrophage cells. J Asian Nat Prod Res. 2018;20(4):385\u201390.","journal-title":"J Asian Nat Prod Res"},{"key":"15438_CR29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ijbiomac.2022.02.073","volume":"205","author":"C Liu","year":"2022","unstructured":"Liu C, Dai KY, Ji HY, Jia XY, Liu AJ. Structural characterization of a low molecular weight polysaccharide and antitumor activity on H22 tumor-bearing mice. Int J Biol Macromol. 2022;205:553\u201362.","journal-title":"Int J Biol Macromol"},{"key":"15438_CR30","doi-asserted-by":"publisher","first-page":"n2026","DOI":"10.1136\/bmj.n2026","volume":"375","author":"LF Newell","year":"2021","unstructured":"Newell LF, Cook RJ. Advances in acute myeloid leukemia. BMJ. 2021;375:n2026.","journal-title":"BMJ"},{"issue":"9","key":"15438_CR31","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1182\/blood-2008-04-150250","volume":"113","author":"MA Sanz","year":"2009","unstructured":"Sanz MA, Grimwade D, Tallman MS, Lowenberg B, Fenaux P, Estey EH, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2009;113(9):1875\u201391.","journal-title":"Blood"},{"issue":"1","key":"15438_CR32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41408-023-00823-9","volume":"13","author":"J Senapati","year":"2023","unstructured":"Senapati J, Sasaki K, Issa GC, Lipton JH, Radich JP, Jabbour E, et al. Management of chronic myeloid leukemia in 2023 - common ground and common sense. Blood Cancer J. 2023;13(1):58.","journal-title":"Blood Cancer J"},{"issue":"5","key":"15438_CR33","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.molcel.2016.02.019","volume":"61","author":"PD Bhola","year":"2016","unstructured":"Bhola PD, Letai A. Mitochondria-judges and executioners of cell death sentences. Mol Cell. 2016;61(5):695\u2013704.","journal-title":"Mol Cell"},{"key":"15438_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221093964","volume":"13","author":"CA Lachowiez","year":"2022","unstructured":"Lachowiez CA, Atluri H, DiNardo CD. Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia. Ther Adv Hematol. 2022;13:20406207221093964.","journal-title":"Ther Adv Hematol"},{"issue":"8","key":"15438_CR35","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.3324\/haematol.2020.263392","volume":"106","author":"M Swaminathan","year":"2021","unstructured":"Swaminathan M, Kantarjian HM, Levis M, Guerra V, Borthakur G, Alvarado Y, et al. A phase I\/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Haematologica. 2021;106(8):2121\u201330.","journal-title":"Haematologica"},{"issue":"8","key":"15438_CR36","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nrc1672","volume":"5","author":"MA Teitell","year":"2005","unstructured":"Teitell MA. The TCL1 family of oncoproteins: co-activators of transformation. Nat Rev Cancer. 2005;5(8):640\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"15438_CR37","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1073\/pnas.97.7.3028","volume":"97","author":"Y Pekarsky","year":"2000","unstructured":"Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S, et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci U S A. 2000;97(7):3028\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"34","key":"15438_CR38","doi-asserted-by":"publisher","first-page":"35890","DOI":"10.1074\/jbc.M400364200","volume":"279","author":"D Auguin","year":"2004","unstructured":"Auguin D, Barthe P, Royer C, Stern MH, Noguchi M, Arold ST, et al. Structural basis for the co-activation of protein kinase B by T-cell leukemia-1 (TCL1) family proto-oncoproteins. J Biol Chem. 2004;279(34):35890\u2013902.","journal-title":"J Biol Chem"},{"issue":"1","key":"15438_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12185-011-0986-5","volume":"95","author":"A Yokohama","year":"2012","unstructured":"Yokohama A, Saitoh A, Nakahashi H, Mitsui T, Koiso H, Kim Y, et al. TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients. Int J Hematol. 2012;95(1):77\u201385.","journal-title":"Int J Hematol"},{"issue":"12","key":"15438_CR40","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/s41588-023-01555-z","volume":"55","author":"SN Stacey","year":"2023","unstructured":"Stacey SN, Zink F, Halldorsson GH, Stefansdottir L, Gudjonsson SA, Einarsson G, et al. Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis. Nat Genet. 2023;55(12):2149\u201359.","journal-title":"Nat Genet"},{"key":"15438_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107844","volume":"225","author":"MF Almatani","year":"2021","unstructured":"Almatani MF, Ali A, Onyemaechi S, Zhao Y, Gutierrez L, Vaikari VP, et al. Strategies targeting FLT3 beyond the kinase inhibitors. Pharmacol Ther. 2021;225:107844.","journal-title":"Pharmacol Ther"},{"key":"15438_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1756-8722-4-13","volume":"4","author":"S Takahashi","year":"2011","unstructured":"Takahashi S. Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications. J Hematol Oncol. 2011;4:13.","journal-title":"J Hematol Oncol"},{"issue":"7958","key":"15438_CR43","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41586-023-05806-1","volume":"616","author":"JS Weinstock","year":"2023","unstructured":"Weinstock JS, Gopakumar J, Burugula BB, Uddin MM, Jahn N, Belk JA, et al. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis. Nature. 2023;616(7958):755\u201363.","journal-title":"Nature"},{"issue":"5","key":"15438_CR44","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11864-023-01066-3","volume":"24","author":"RP Gale","year":"2023","unstructured":"Gale RP. Can immune therapy cure acute myeloid leukemia? Curr Treat Options Oncol. 2023;24(5):381\u20136.","journal-title":"Curr Treat Options Oncol"},{"issue":"5","key":"15438_CR45","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/ajh.24679","volume":"92","author":"Z Hu","year":"2017","unstructured":"Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, et al. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia. Am J Hematol. 2017;92(5):441\u20137.","journal-title":"Am J Hematol"},{"issue":"3\u20134","key":"15438_CR46","doi-asserted-by":"publisher","first-page":"2000185","DOI":"10.1002\/star.202000185","volume":"73","author":"Q Guo","year":"2021","unstructured":"Guo Q, Li BL, Bao CL, Li YX, Cao YL, Wang CX, Wu WH. Bletilla striata Polysaccharides improve hemostatic, antiinflammatory efficacy, and platelet aggregation in gingivitis rat model. Starch-Starke. 2021;73(3\u20134):2000185.","journal-title":"Starch-Starke"},{"issue":"3","key":"15438_CR47","first-page":"470","volume":"20","author":"XM He","year":"2022","unstructured":"He XM, Chen CW, Zhu FC, Qiao DL, Chen NF, Song C. The effects of polysaccharides on antioxidant and immunomodulatory activities of mice. Curr Top Nutraceut R. 2022;20(3):470\u20137.","journal-title":"Curr Top Nutraceut R"},{"issue":"06","key":"15438_CR48","first-page":"676","volume":"24","author":"HM Qiu","year":"2011","unstructured":"Qiu HM, Zhang Y, Zhou QX. Regulatory effect of Bletilla striata polysaccharide on immune function of mice (In Chinese). Chin J Biol. 2011;24(06):676\u20138.","journal-title":"Chin J Biol"},{"issue":"2","key":"15438_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1263\/jbb.105.85","volume":"105","author":"H Diao","year":"2008","unstructured":"Diao H, Li X, Chen J, Luo Y, Chen X, Dong L, et al. Bletilla striata polysaccharide stimulates inducible nitric oxide synthase and proinflammatory cytokine expression in macrophages. J Biosci Bioeng. 2008;105(2):85\u20139.","journal-title":"J Biosci Bioeng"},{"issue":"12","key":"15438_CR50","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.14233\/ajchem.2014.16500","volume":"26","author":"Q Li","year":"2014","unstructured":"Li Q, Li K, Huang SS, Zhang HL, Diao YP. Optimization of extraction process and antibacterial activity of polysaccharides. Asian J Chem. 2014;26(12):3574\u201380.","journal-title":"Asian J Chem"},{"key":"15438_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113519","author":"F Zhou","year":"2022","unstructured":"ZhouF, Feng R, Dai O, Yang L, Liu Y, Tian YC, et al. Antiproliferative and proapoptotic effects of phenanthrene derivatives isolated from Bletilla striataon A549 lung cancer cells. Molecules. 2022;27(11):3519. https:\/\/doi.org\/10.3390\/molecules27113519.","journal-title":"Molecules"},{"issue":"10","key":"15438_CR52","first-page":"2224","volume":"31","author":"LF Wang","year":"2013","unstructured":"Wang LF, Li WP, Shen YP, Zhou YH, Ding ZS, Jiang FS. Studies on active fraction in rhizoma Bletillaestriatae inducing HL60 cells apoptosis and lts related mechanisms (in Chinese). Chin Arch Tradit Chin. 2013;31(10):2224\u20136.","journal-title":"Chin Arch Tradit Chin"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15438-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15438-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15438-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:03:31Z","timestamp":1768925011000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15438-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15438"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15438-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All GWAS studies included in this paper were ethically approved by their institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"91"}}